{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:27:00Z","timestamp":1790130420696,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ygyno.2007.07.024","type":"journal-article","created":{"date-parts":[[2007,9,7]],"date-time":"2007-09-07T13:21:44Z","timestamp":1189171304000},"page":"S223-S229","source":"Crossref","is-referenced-by-count":31,"special_numbering":"S","title":["Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients"],"prefix":"10.1016","volume":"107","author":[{"given":"J. Salvador","family":"Saldivar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Therese","family":"Vlastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Follen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2007.07.024_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"s1","key":"10.1016\/j.ygyno.2007.07.024_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1525-1438.2005.15351.x","article-title":"Treatment goals in ovarian cancer","volume":"15","author":"Ozols","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2007.07.024_bib3","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2007.07.024_bib4","first-page":"340","article-title":"Chemotherapy of advanced ovarian cancer","volume":"25","author":"McGuire","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ygyno.2007.07.024_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/gyno.1993.1252","article-title":"Clinical reversal of drug resistance in ovarian cancer","volume":"51","author":"Ozols","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.07.024_bib6","first-page":"1439","article-title":"Mechanism of action of cis-dichlorodiamineplatinum (II)","volume":"63","author":"Zwelling","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ygyno.2007.07.024_bib7","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1073\/pnas.85.12.4158","article-title":"The major adduct of the antitumor drug cis-diamminedichloroplatinum (II) with DNA bends the duplex by approximate equal to 40 degrees toward the major groove","volume":"85","author":"Rice","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2007.07.024_bib8","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1073\/pnas.84.14.5024","article-title":"Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy","volume":"84","author":"Reed","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2007.07.024_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","article-title":"Platinum-DNA adduct, nucleotide excision repair and platinum-based anticancer chemotherapy","volume":"24","author":"Reed","year":"1998","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ygyno.2007.07.024_bib10","first-page":"1513","article-title":"Polymorphisms in DNA repair genes and associations with cancer risk","volume":"11","author":"Goode","year":"2002","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ygyno.2007.07.024_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0300-9084(99)80045-5","article-title":"Cancer from the outside, aging from the inside: mouse models to study the consequences of defective nucleotide excision repair","volume":"81","author":"de Boer","year":"1999","journal-title":"Biochimie"},{"key":"10.1016\/j.ygyno.2007.07.024_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/35094000","article-title":"How nucleotide excision repair protects against cancer","volume":"1","author":"Friedberg","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2007.07.024_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/carcin\/21.3.453","article-title":"Nucleotide excision repair and human syndromes","volume":"21","author":"de Boer","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2007.07.024_bib14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archderm.130.8.1018","article-title":"The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer","volume":"130","author":"Kraemer","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ygyno.2007.07.024_bib15","first-page":"8654","article-title":"A xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer","volume":"61","author":"Park","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2007.07.024_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3816\/CLC.2003.n.004","article-title":"Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine\/cisplatin-treated advanced non-small-cell lung cancer patients","volume":"4","author":"Camps","year":"2003","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ygyno.2007.07.024_bib17","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy","volume":"22","author":"Gurubhagavatula","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2007.07.024_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2003.11.019","article-title":"Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy","volume":"44","author":"Ryu","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ygyno.2007.07.024_bib19","series-title":"Histological typing of ovarian tumours","author":"Scully","year":"1999"},{"key":"10.1016\/j.ygyno.2007.07.024_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0090-8258(86)90092-2","volume":"25","author":"Staging Announcement: FIGO Cancer Committee","year":"1986","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.07.024_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2007.07.024_bib22","series-title":"Gynecologic cancer: controversies in management","first-page":"447","article-title":"Decision-making in the management of recurrent epithelial ovarian cancer","author":"Markman","year":"2004"},{"key":"10.1016\/j.ygyno.2007.07.024_bib23","author":"STATA release 7.0 reference manual","year":"2000"},{"key":"10.1016\/j.ygyno.2007.07.024_bib24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1470-2045(01)00454-5","article-title":"Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance","volume":"2","author":"McHugh","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2007.07.024_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0304-3835(96)04428-X","article-title":"Enhanced XPA mRNA levels in cisplatin-resistant human ovarian cancer are not associated with XPA mutations or gene amplification","volume":"108","author":"States","year":"1996","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2007.07.024_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/carcin\/24.3.505","article-title":"XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity","volume":"24","author":"Wu","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2007.07.024_bib27","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/emboj\/18.5.1357","article-title":"Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH","volume":"18","author":"Coin","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.ygyno.2007.07.024_bib28","first-page":"4899","article-title":"Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells","volume":"62","author":"Furuta","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2007.07.024_bib29","first-page":"5457","article-title":"Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD","volume":"62","author":"Aloyz","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2007.07.024_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1368-8375(01)00106-3","article-title":"XPD\/ERCC2 EXON 8 polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck","volume":"38","author":"Sturgis","year":"2002","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ygyno.2007.07.024_bib31","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/nar\/29.7.1443","article-title":"The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms","volume":"29","author":"Emmert","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ygyno.2007.07.024_bib32","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1074\/jbc.272.25.16030","article-title":"The non-catalytic function of XPG protein during dual incision in human nucleotide excision repair","volume":"272","author":"Wakasugi","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2007.07.024_bib33","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0959-8049(98)00230-5","article-title":"Pharmacogenetics and cancer chemotherapy","volume":"34","author":"Iyer","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2007.07.024_bib34","first-page":"107","article-title":"Using genetic variations to optimize cancer chemotherapy","volume":"1","author":"McLeod","year":"2003","journal-title":"Clin Adv Hematol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807004957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807004957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T16:55:12Z","timestamp":1546620912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825807004957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0090825807004957"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2007.07.024","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}